Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher J Nolan

Showing results (11-20 of 105) with videos related to

Pageof 11
Sort By:
Trends in Endocrinology and Metabolism: TEM|May 2, 2024
Disentangling fetal insulin hypersecretion and insulin resistanceChristopher J Nolan, Gernot Desoye
Diabetes|January 23, 2016
Reversibility of Defects in Proinsulin Processing and Islet β-Cell Failure in Obesity-Related Type 2 DiabetesChristopher J Nolan, Viviane Delghingaro-Augusto
Journal of Gastroenterology and Hepatology|August 4, 2009
Lipotoxicity: why do saturated fatty acids cause and monounsaturates protect against it?Christopher J Nolan, Claire Z Larter
Diabetes|May 24, 2014
RNA sequencing of all transcripts and how islet β-cells failChristopher J Nolan, Viviane Delghingaro-Augusto
Australian Prescriber|October 30, 2025
Gestational diabetes: update on screening, diagnosis and maternal managementStephanie Baddock, Carolyn Petersons, Christopher J Nolan
The Australian & New Zealand Journal of Obstetrics & Gynaecology|August 4, 2016
The gestational diabetes tsunami: Can we survive it?Peter Scott, Yan Zhang, Christopher J Nolan
Lancet (London, England)|June 28, 2011
Type 2 diabetes across generations: from pathophysiology to prevention and managementChristopher J Nolan, Peter Damm, Marc Prentki
Survey of Ophthalmology|November 24, 2024
Functional diabetic retinopathy: A new concept to improve management of diabetic retinal diseasesBhim B Rai, Ted Maddess, Christopher J Nolan
Diabetologia|January 23, 2018
Diabetes in pregnancy: a new decade of challenges aheadUte Schaefer-Graf, Angela Napoli, Christopher J Nolan, et al.
The Lancet. Diabetes & Endocrinology|March 14, 2014
Intensive insulin for type 2 diabetes: the risk of causing harmChristopher J Nolan, Neil B Ruderman, Marc Prentki
Pageof 11

Showing results (11-20 of 105) with videos related to

Sort By:
Pageof 11
Trends in Endocrinology and Metabolism: TEM|May 2, 2024
Disentangling fetal insulin hypersecretion and insulin resistanceChristopher J Nolan, Gernot Desoye
Diabetes|January 23, 2016
Reversibility of Defects in Proinsulin Processing and Islet β-Cell Failure in Obesity-Related Type 2 DiabetesChristopher J Nolan, Viviane Delghingaro-Augusto
Journal of Gastroenterology and Hepatology|August 4, 2009
Lipotoxicity: why do saturated fatty acids cause and monounsaturates protect against it?Christopher J Nolan, Claire Z Larter
Diabetes|May 24, 2014
RNA sequencing of all transcripts and how islet β-cells failChristopher J Nolan, Viviane Delghingaro-Augusto
Australian Prescriber|October 30, 2025
Gestational diabetes: update on screening, diagnosis and maternal managementStephanie Baddock, Carolyn Petersons, Christopher J Nolan
The Australian & New Zealand Journal of Obstetrics & Gynaecology|August 4, 2016
The gestational diabetes tsunami: Can we survive it?Peter Scott, Yan Zhang, Christopher J Nolan
Lancet (London, England)|June 28, 2011
Type 2 diabetes across generations: from pathophysiology to prevention and managementChristopher J Nolan, Peter Damm, Marc Prentki
Survey of Ophthalmology|November 24, 2024
Functional diabetic retinopathy: A new concept to improve management of diabetic retinal diseasesBhim B Rai, Ted Maddess, Christopher J Nolan
Diabetologia|January 23, 2018
Diabetes in pregnancy: a new decade of challenges aheadUte Schaefer-Graf, Angela Napoli, Christopher J Nolan, et al.
The Lancet. Diabetes & Endocrinology|March 14, 2014
Intensive insulin for type 2 diabetes: the risk of causing harmChristopher J Nolan, Neil B Ruderman, Marc Prentki
Pageof 11